gland pharma glp-1 manufacturing capacity India's pharmaceutical industry is witnessing another massive strategic move ππ Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a βΉ1,369 crore deal, signaling stronger expansion, integrated GLP-1 Receptor Agonist Market Size
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5



























